Table 1.
Characterizing information for patients and controls.
| Measure | Control Mean (SD) | Patient Mean (SD) | p-value |
|---|---|---|---|
| Age | 45.01 (11.30) | 45.47 (8.40) | 0.860 |
| Age at Illness Onset | - | 23.28 (7.854) | |
| Education (years) | 15.15 (2.31) | 12.94 (2.36) | 0.001 |
| Paternal Education (years) | 14.95 (3.48) | 13.91 (4.37) | 0.334 |
| Gender (M:F) | 14:12 | 23:11 | 0.298 |
| Race | 0.239 | ||
| African American | 5 | 12 | |
| Caucasian | 21 | 21 | |
| Other | 0 | 1 | |
| Medication Regimens | |||
| Single First-generation Med | 7 | ||
| Haloperidol | - | 4 | |
| Fluphenazine | 3 | ||
| Single Second-generation Med | 16 | ||
| Clozapine | 7 | ||
| Risperidone | - | 4 | |
| Olanzapine | 4 | ||
| Aripiprazole | 1 | ||
| Multiple Antipsychotics | 11 | ||
| Clozapine + Risperidone | - | 10 | |
| Clozapine + Fluphenazine | 1 | ||
| Clinical Ratings | |||
| BPRS | - | 35.97 (10.51) | |
| SANS | - | 33.18 (16.82) | |
| Calgary Depression Scale | - | 3.30 (3.63) | |
| Standard Neuropsychology | |||
| Wechsler Test of Adult Reading | 110.38 (11.62) | 98.24 (17.15) | =0.002 |
| Hopkins Verbal Learning Score | 28.04 (4.96) | 21.76 (5.53) | <0.001 |
| Spatial Span Scaled Score | 11.46 (2.16) | 7.97 (3.03) | <0.001 |
| Letter-number Sequencing | 16.12 (3.01) | 11.74 (3.23) | <0.001 |